Brian M Stuglik sold $5,864 of VSTM
director at Verastem, Inc.. 587 shares at an average of $9.99, traded Sep 16, 2025, filed Sep 18, 2025.
Score components
- +15RoleDirector
- 0Trade size$6k at market
- 0Share of holdings soldSold 0.6% of holdings
- +15Cluster4 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-25-091362, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 16, 2025 | SOpen-market sale Common Stock10b5-1 | -587 | $9.99 | $5,864 | 101,739 | Sep 18, 2025 |
Related signals
Other insiders at Verastem, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 10Weak | Verastem, Inc. | Daniel Calkins Chief Financial Officer | $21k 2,566 shares | -2% | |
| 28Weak | Verastem, Inc. | Dan Paterson President and CEO | $353k 44,121 shares | -6% | |
| 10Weak | Verastem, Inc. | Daniel Calkins Chief Financial Officer | $424 55 shares | -0% | |
| 10Weak | Verastem, Inc. | Daniel Calkins Chief Financial Officer | $629 80 shares | -0% | |
| 3Weak | Verastem, Inc. | Robert E. Gagnon director | $2,587 283 shares | -1% | |
| 8Weak | Verastem, Inc. | Paul A. Bunn director | $63k 6,250 shares | -75% | |
| 23Weak | Verastem, Inc. | Paul A. Bunn director | $75k 8,333 shares | -50% | |
| 17Weak | Verastem, Inc. | Daniel Calkins Chief Financial Officer | $748 82 shares | -0% | |
| 10Weak | Verastem, Inc. | Robert E. Gagnon director | $2,807 281 shares | -1% | |
| 20Weak | Verastem, Inc. | Dan Paterson President and CEO | $3,896 390 shares | -0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.